134 related articles for article (PubMed ID: 24342320)
1. Efficacy and safety of a novel nano-porous polymer-free sirolimus-eluting stent in pigs.
Chen M; Zheng B; Wu Z; Peng HY; Wang XG; Zhang B; Huo Y
Chin Med J (Engl); 2013; 126(24):4731-5. PubMed ID: 24342320
[TBL] [Abstract][Full Text] [Related]
2. Investigation of long-term implantation of BuMA stent in a porcine coronary model.
Chen M; Wang XG; Zheng B; Peng HY; Zhang XY; Zhang B; Huo Y
Chin Med J (Engl); 2012 Nov; 125(22):4083-7. PubMed ID: 23158147
[TBL] [Abstract][Full Text] [Related]
3. Polymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model.
Tada N; Virmani R; Grant G; Bartlett L; Black A; Clavijo C; Christians U; Betts R; Savage D; Su SH; Shulze J; Kar S
Circ Cardiovasc Interv; 2010 Apr; 3(2):174-83. PubMed ID: 20407114
[TBL] [Abstract][Full Text] [Related]
4. A novel polymer-free paclitaxel-eluting stent with a nanoporous surface for rapid endothelialization and inhibition of intimal hyperplasia: Comparison with a polymer-based sirolimus-eluting stent and bare metal stent in a porcine model.
Jia H; Liu H; Kong J; Hou J; Wu J; Zhang M; Tian J; Liu H; Ma L; Hu S; Huang X; Zhang S; Zhang S; Yu B; Jang IK
J Biomed Mater Res A; 2011 Sep; 98(4):629-37. PubMed ID: 21732525
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of novel biodegradable, polymer-coated, sirolimus-eluting stents on neointimal formation in a porcine coronary model.
Peng HY; Chen M; Zheng B; Wang XG; Huo Y
Int Heart J; 2009 Nov; 50(6):811-22. PubMed ID: 19952477
[TBL] [Abstract][Full Text] [Related]
6. Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating.
Jabara R; Chronos N; Robinson K
Catheter Cardiovasc Interv; 2008 Aug; 72(2):186-94. PubMed ID: 18651646
[TBL] [Abstract][Full Text] [Related]
7. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
[TBL] [Abstract][Full Text] [Related]
8. [Stents coated with sirolimus and anti-CD34 antibody can optimize the performance of sirolimus-eluting stents].
Song XT; Zhu HG; Yang XS; Yuan F; Lü SZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Nov; 39(11):997-1004. PubMed ID: 22336451
[TBL] [Abstract][Full Text] [Related]
9. Vascular response and mechanical integrity of the new biodegradable polymer coated sirolimus-eluting PROLIM stent implanted in porcine coronary arteries.
Milewski K; Gorycki B; Buszman PP; Jelonek M; Beaudry D; Lapointe JM; Guy LG; Abusamra M; Pająk J; Kinasz W; Wojakowski W; Leclerc G; Gil RJ; Buszman PE
Kardiol Pol; 2012; 70(7):703-11. PubMed ID: 22825946
[TBL] [Abstract][Full Text] [Related]
10. Impact of polymer formulations on neointimal proliferation after zotarolimus-eluting stent with different polymers: insights from the RESOLUTE trial.
Waseda K; Ako J; Yamasaki M; Koizumi T; Sakurai R; Hongo Y; Koo BK; Ormiston J; Worthley SG; Whitbourn RJ; Walters DL; Meredith IT; Fitzgerald PJ; Honda Y
Circ Cardiovasc Interv; 2011 Jun; 4(3):248-55. PubMed ID: 21586691
[TBL] [Abstract][Full Text] [Related]
11. Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient-years of follow-up from randomized trials.
Bangalore S; Amoroso N; Fusaro M; Kumar S; Feit F
Circ Cardiovasc Interv; 2013 Aug; 6(4):378-90. PubMed ID: 23922145
[TBL] [Abstract][Full Text] [Related]
12. Preclinical and early clinical experience with a biodegradable polymer-based, rapamycin-eluting, Indian drug-eluting coronary stent: the BIO-RAPID study.
Bhargava B; Karthikeyan G; Shankar PB; Seth S; Singh S; Pr U; Lal AV; Mohanty M
Indian Heart J; 2008; 60(3):228-32. PubMed ID: 19240312
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Smits PC; Kaiser C; D'Ascenzo F; Frati G; Mancone M; Genereux P; Stone GW
J Am Coll Cardiol; 2014 Feb; 63(4):299-307. PubMed ID: 24211507
[TBL] [Abstract][Full Text] [Related]
14. Differential healing responses in polymer- and nonpolymer-based sirolimus-eluting stents.
John MC; Wessely R; Kastrati A; Schömig A; Joner M; Uchihashi M; Crimins J; Lajoie S; Kolodgie FD; Gold HK; Virmani R; Finn AV
JACC Cardiovasc Interv; 2008 Oct; 1(5):535-44. PubMed ID: 19463356
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of experimental neointimal hyperplasia and neoatherosclerosis by local, stent-mediated delivery of everolimus.
Zhao HQ; Nikanorov A; Virmani R; Schwartz LB
J Vasc Surg; 2012 Dec; 56(6):1680-8. PubMed ID: 22841285
[TBL] [Abstract][Full Text] [Related]
16. A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results.
Xu B; Dou KF; Han YL; Lü SZ; Yang YJ; Huo Y; Wang LF; Chen YD; Wang HC; Li WM; Chen JY; Wang L; Wang Y; Ge JB; Li W; Gao RL
Chin Med J (Engl); 2011 Mar; 124(6):811-6. PubMed ID: 21518585
[TBL] [Abstract][Full Text] [Related]
17. Six-month angiographic and one-year clinical outcomes of polymer free paclitaxel-eluting stent in patients with ST-segment elevation myocardial infarction: a comparison with permanent polymer sirolimus-eluting stent.
Dang Q; Li YJ; Gao L; Jin Z; Gou LX
Chin Med J (Engl); 2012 Oct; 125(19):3393-7. PubMed ID: 23044294
[TBL] [Abstract][Full Text] [Related]
18. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.
Simsek C; Magro M; Boersma E; Onuma Y; Nauta S; Daemen J; Gaspersz M; van Geuns RJ; van der Giessen W; van Domburg R; Serruys P
J Invasive Cardiol; 2011 Aug; 23(8):336-41. PubMed ID: 21828397
[TBL] [Abstract][Full Text] [Related]
19. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
[TBL] [Abstract][Full Text] [Related]
20. Two-year clinical registry follow-up of endothelial progenitor cell capture stent versus sirolimus-eluting bioabsorbable polymer-coated stent versus bare metal stents in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction.
Chong E; Poh KK; Liang S; Lee RC; Low A; Teo SG; Tan HC
J Interv Cardiol; 2010 Apr; 23(2):101-8. PubMed ID: 20236214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
